[{"address1": "650 Castro Street", "address2": "Suite 450", "city": "Mountain View", "state": "CA", "zip": "94041", "country": "United States", "phone": "650 200 0412", "website": "https://www.altoneuroscience.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Alto Neuroscience, Inc. operates as a clinical-stage biopharmaceutical company in the United States. The company's product pipeline includes ALTO-100, which is in Phase 2b clinical trial for the treatment of patients with bipolar depression (BPD). It also develops ALTO-300, a small molecule melatonergic agonist and serotonergic antagonist with antidepressant properties, which is in Phase 2b clinical trial to treat patients with major depressive disorder (MDD); ALTO-101, a novel small molecule phosphodiesterase 4 inhibitor that is in Phase 2 proof-of-concept (POC) trial for the treatment of cognitive impairment associated with schizophrenia; ALTO-203, a novel small-molecule histamine H3 receptor inverse agonist, which is in Phase 2 POC trial to treat patients with MDD and higher levels of anhedonia; and ALTO-202, an investigational orally bioavailable antagonist of the GluN2B subunit of the NMDA receptor that is in Phase 1 clinical trial for the treatment of MDD. The company was incorporated in 2019 and is headquartered in Mountain View, California.", "fullTimeEmployees": 76, "companyOfficers": [{"maxAge": 1, "name": "Dr. Amit  Etkin M.D., Ph.D.", "age": 48, "title": "Founder, Chairman of the Board, CEO & President", "yearBorn": 1977, "fiscalYear": 2024, "totalPay": 995998, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Nicholas C. Smith", "age": 36, "title": "CFO & Chief Business Officer", "yearBorn": 1989, "fiscalYear": 2024, "totalPay": 680467, "exercisedValue": 0, "unexercisedValue": 217377}, {"maxAge": 1, "name": "Mr. Michael C. Hanley M.B.A.", "age": 52, "title": "Chief Operating Officer", "yearBorn": 1973, "fiscalYear": 2024, "totalPay": 623006, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Dan  Segal B.Sc. (Hons), BCom, CA, MSc", "age": 63, "title": "Co-Founder & Strategic Advisor", "yearBorn": 1962, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Erin R. McQuade J.D.", "age": 50, "title": "General Counsel, Chief Administrative Officer & Corporate Secretary", "yearBorn": 1975, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Adam  Savitz M.D., Ph.D.", "age": 59, "title": "Chief Medical Officer", "yearBorn": 1966, "fiscalYear": 2024, "totalPay": 579569, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Jessica  Powell", "age": 50, "title": "Chief Development Officer", "yearBorn": 1975, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1735603200, "executiveTeam": [], "maxAge": 86400, "priceHint": 2, "previousClose": 14.11, "open": 14.35, "dayLow": 13.9121, "dayHigh": 15.4, "regularMarketPreviousClose": 14.11, "regularMarketOpen": 14.35, "regularMarketDayLow": 13.9121, "regularMarketDayHigh": 15.4, "payoutRatio": 0.0, "beta": 2.851, "forwardPE": -7.1455398, "volume": 274277, "regularMarketVolume": 274277, "averageVolume": 322836, "averageVolume10days": 209560, "averageDailyVolume10Day": 209560, "bid": 15.32, "ask": 15.34, "bidSize": 200, "askSize": 200, "marketCap": 472829632, "fiftyTwoWeekLow": 1.6, "fiftyTwoWeekHigh": 20.908, "allTimeHigh": 24.0, "allTimeLow": 1.6, "fiftyDayAverage": 16.1158, "twoHundredDayAverage": 7.63305, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 360411616, "profitMargins": 0.0, "floatShares": 20754486, "sharesOutstanding": 31066335, "sharesShort": 2171494, "sharesShortPriorMonth": 2781726, "sharesShortPreviousMonthDate": 1765756800, "dateShortInterest": 1768435200, "sharesPercentSharesOut": 0.0699, "heldPercentInsiders": 0.06439, "heldPercentInstitutions": 0.66149, "shortRatio": 5.51, "shortPercentOfFloat": 0.0858, "impliedSharesOutstanding": 31066335, "bookValue": 4.106, "priceToBook": 3.7067707, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1759190400, "netIncomeToCommon": -62257000, "trailingEps": -2.3, "forwardEps": -2.13, "enterpriseToEbitda": -5.491, "52WeekChange": 3.162242, "SandP52WeekChange": 0.120657206, "quoteType": "EQUITY", "currentPrice": 15.22, "targetHighPrice": 50.0, "targetLowPrice": 13.0, "targetMeanPrice": 31.125, "targetMedianPrice": 28.5, "recommendationKey": "none", "numberOfAnalystOpinions": 8, "totalCash": 137816000, "totalCashPerShare": 4.436, "ebitda": -65632000, "totalDebt": 25398000, "quickRatio": 15.237, "currentRatio": 15.417, "debtToEquity": 22.767, "returnOnAssets": -0.24476999, "returnOnEquity": -0.45014, "freeCashflow": -36611124, "operatingCashflow": -53274000, "grossMargins": 0.0, "ebitdaMargins": 0.0, "operatingMargins": 0.0, "financialCurrency": "USD", "symbol": "ANRO", "language": "en-US", "region": "US", "typeDisp": "Equity", "triggerable": true, "customPriceAlertConfidence": "HIGH", "corporateActions": [], "regularMarketChangePercent": 7.86677, "regularMarketPrice": 15.22, "postMarketTime": 1770425881, "regularMarketTime": 1770411602, "exchange": "NYQ", "messageBoardId": "finmb_1675972978", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EST", "gmtOffSetMilliseconds": -18000000, "market": "us_market", "esgPopulated": false, "marketState": "CLOSED", "fullExchangeName": "NYSE", "averageDailyVolume3Month": 322836, "fiftyTwoWeekLowChange": 13.62, "fiftyTwoWeekLowChangePercent": 8.5125, "fiftyTwoWeekRange": "1.6 - 20.908", "fiftyTwoWeekHighChange": -5.6880007, "fiftyTwoWeekHighChangePercent": -0.272049, "fiftyTwoWeekChangePercent": 316.22418, "earningsTimestamp": 1762954200, "earningsTimestampStart": 1762954200, "earningsTimestampEnd": 1762954200, "isEarningsDateEstimate": false, "epsTrailingTwelveMonths": -2.3, "epsForward": -2.13, "epsCurrentYear": -2.35, "priceEpsCurrentYear": -6.4765964, "fiftyDayAverageChange": -0.8958006, "fiftyDayAverageChangePercent": -0.055585235, "twoHundredDayAverageChange": 7.5869503, "twoHundredDayAverageChangePercent": 0.9939605, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "cryptoTradeable": false, "shortName": "Alto Neuroscience, Inc.", "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1706884200000, "postMarketChangePercent": 0.722731, "postMarketPrice": 15.33, "postMarketChange": 0.10999966, "regularMarketChange": 1.11, "regularMarketDayRange": "13.9121 - 15.4", "displayName": "Alto Neuroscience", "trailingPegRatio": null, "__fetch_time": "2026-02-07"}]